GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Cyclically Adjusted Revenue per Share

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Cyclically Adjusted Revenue per Share : ¥1.05 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Anhui Anke Biotechnology (Group) Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.392. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥1.05 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Anhui Anke Biotechnology (Group) Co's average Cyclically Adjusted Revenue Growth Rate was 15.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Anhui Anke Biotechnology (Group) Co was 18.60% per year. The lowest was 17.00% per year. And the median was 17.70% per year.

As of today (2024-05-20), Anhui Anke Biotechnology (Group) Co's current stock price is ¥10.17. Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥1.05. Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio of today is 9.69.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Anhui Anke Biotechnology (Group) Co was 34.20. The lowest was 7.93. And the median was 18.90.


Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Revenue per Share Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.63 0.75 0.88 1.01

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.94 0.98 1.01 1.05

Competitive Comparison of Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio falls into.



Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Anhui Anke Biotechnology (Group) Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.392/115.2271*115.2271
=0.392

Current CPI (Mar. 2024) = 115.2271.

Anhui Anke Biotechnology (Group) Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.095 98.200 0.111
201409 0.103 98.900 0.120
201412 0.117 99.000 0.136
201503 0.079 99.900 0.091
201506 0.136 99.500 0.157
201509 0.120 100.500 0.138
201512 0.118 100.600 0.135
201603 0.119 102.200 0.134
201606 0.111 101.400 0.126
201609 0.141 102.400 0.159
201612 0.187 102.600 0.210
201703 0.128 103.200 0.143
201706 0.171 103.100 0.191
201709 0.190 104.100 0.210
201712 0.253 104.500 0.279
201803 0.181 105.300 0.198
201806 0.221 104.900 0.243
201809 0.247 106.600 0.267
201812 0.277 106.500 0.300
201903 0.235 107.700 0.251
201906 0.240 107.700 0.257
201909 0.243 109.800 0.255
201912 0.310 111.200 0.321
202003 0.194 112.300 0.199
202006 0.245 110.400 0.256
202009 0.269 111.700 0.277
202012 0.356 111.500 0.368
202103 0.296 112.662 0.303
202106 0.300 111.769 0.309
202109 0.340 112.215 0.349
202112 0.443 113.108 0.451
202203 0.339 114.335 0.342
202206 0.320 114.558 0.322
202209 0.374 115.339 0.374
202212 0.393 115.116 0.393
202303 0.352 115.116 0.352
202306 0.429 114.558 0.432
202309 0.424 115.339 0.424
202312 0.524 114.781 0.526
202403 0.392 115.227 0.392

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Anhui Anke Biotechnology (Group) Co  (SZSE:300009) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.17/1.05
=9.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Anhui Anke Biotechnology (Group) Co was 34.20. The lowest was 7.93. And the median was 18.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Anhui Anke Biotechnology (Group) Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Anke Biotechnology (Group) Co (SZSE:300009) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Headlines

No Headlines